A Study Of Acute Decompensated Heart Failure
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT07572955
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Acute Decompensated Heart Failure
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Lung Ultrasound — DIAGNOSTIC_TESTPatients will undergo lung ultrasound assessments at hospital admission, daily throughout admission, and at hospital discharge.
Study Details
The purpose of this study is to examine shorter hospitalization length as well as a reduced rates of recurrent heart failure hospitalization compared to current standard of care in Acute Decompensated Heart Failure. A 1-day reduction in hospital length of stay in unblinded subjects receiving daily HF-FOCUS examinations compared to a blinded standard of care arm.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 500 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Active Comparator: Group 1Patients undergoing daily lung ultrasound with the results reported to the provider care teams on admission and each morning
- Experimental: Group 2Patients undergoing daily lung ultrasound but the results will be blinded to the provider care teams
Primary Outcome Measure
Number of days in the hospital [ Time Frame: Baseline ]
Central Contacts
- Andy Dang507-255-7752
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Jared Bird, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site
Related Studies
- Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)PHASE3 · Recruiting · Reprieve Cardiovascular, Inc · Irvine, California
- Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart FailureRecruiting · UConn Health · Farmington, Connecticut
- Low Level Tragus Stimulation in Acute Decompensated Heart FailureRecruiting · University of Oklahoma · Oklahoma City, Oklahoma
- Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart FailurePHASE3 · Not Yet Recruiting · University of Texas Southwestern Medical Center · Dallas, Texas